Thomas E. Keane, MD, presented “Panel on Androgen Deprivation Therapy: A Closer Review of the Cardiovascular Risk” during the 30th Annual International Prostate Cancer Update on January 23rd, 2020 in Beaver Creek, Colorado.
How to cite: Keane, Thomas E. “Panel on Androgen Deprivation Therapy: A Closer Review of the Cardiovascular Risk” January 23rd, 2020. Accessed May 2021. https://grandroundsinurology.com/panel-on-androgen-deprivation-therapy-a-closer-review-of-the-cardiovascular-risk/
Panel on Androgen Deprivation Therapy: A Closer Review of the Cardiovascular Risk – Summary:
Thomas E. Keane, MD, Professor and Chairman of the Department of Urology at the Medical University of South Carolina, Charleston, leads a panel discussion including Lawrence I. Karsh, MD, Peter J. Rossi, MD, and Neal D. Shore, MD, FACS, to discuss the process of treating prostate cancer in a patient who is at risk for cardiovascular disease and how extra care is needed in such cases. They also stress the importance of being in contact with a patient’s PCP even if one chooses to do their own assessment of patient risk, as well as when ADT should not be considered an option, such as in the case of a patient with significant CAD and elevated liver enzymes. The group, over the course of the panel, discuss the many ADT options available, including their strengths and weaknesses.
About The 30th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Keane led this panel discussion during the 30th iteration of the meeting in January 2020.
For further educational activities from this conference, visit our collection page.